Calumet, Inc. (CLMT) Stock Analysis
Basic Materials · Specialty Chemicals · NasdaqGS
Calumet, Inc. (CLMT) posted $4.14B in revenue for fiscal 2025 (down 1.2% year over year), with a net loss of $33.80M, and has compounded revenue about -4.1%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on Calumet, Inc.
Calumet, Inc. has grown revenue from $4.69B to $4.14B over the last 4 fiscal years, compounding about -4.1% a year. The most recent year was down 1.2%, so growth is actually accelerating.
Net margin sits at -0.8%, up 4.5 points year over year on a 5.9% gross margin. It carries about $2.23B of total debt.
At today's valuation the market is pricing in roughly 21.3% annual free-cash-flow growth. The one thing worth a second look in the filings is share count rising (dilution).
Synthesised from Calumet, Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →
Calumet, Inc. revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $4.69B | $4.18B | $4.19B | $4.14B |
| Gross profit | $351.70M | $451.70M | $230.80M | $245.70M |
| Net income | $-173.30M | $48.10M | $-222.00M | $-33.80M |
| Net margin | -3.7% | 1.2% | -5.3% | -0.8% |
Source: Calumet, Inc. SEC filings (10-K).
Calumet, Inc.: 3 potential red flags in the filings
Patterns in the filed statements worth a second look — computed and cited, not AI guesswork, and not a signal to sell. The kind of thing that hides in a 10-K.
- Share count rising (dilution)Shares outstanding grew 9.6% over 3 years (79.2M → 86.8M) — existing holders' stakes are being diluted.
- Heavy debt loadTotal debt of $2389.7M is 21.9× last year's operating cash flow — it would take years of cash flow to clear.
- Currently unprofitableThe latest fiscal year was a net loss (net margin -0.8%).
What growth is priced into CLMT stock?
At today's market cap of $3.07B, Calumet, Inc. is priced for free-cash-flow growth of about 21.3% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $56.60M from the FY ending 2025-12-31). This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 4 years of Calumet, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track CLMT in your portfolio →
Calumet, Inc. financial history by metric
About Calumet, Inc.
Calumet, Inc. manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. It operates through Specialty Products and Solutions; Performance Brands; and Montana/Renewables segments. The Specialty Products and Solutions segment manufactures and markets various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The Montana/Renewables segment processes geographically advantaged renewable feedstocks into renewable diesel, aviation fuel, and renewable naphtha. This segment also engages in the process of Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. The Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. It serves wholesale distributors and retail chains. Calumet, Inc. was founded in 1919 and is headquartered in Indianapolis, Indiana.
Calumet, Inc. — frequently asked questions
What is Calumet, Inc.'s revenue?
Calumet, Inc. (CLMT) reported revenue of $4.14B for fiscal year 2025, down 1.2% from the prior year, according to its SEC filings.
Is Calumet, Inc. profitable?
No — CLMT reported a net loss of $-33.80M in fiscal 2025.
What is CLMT's P/E ratio?
Calumet, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is Calumet, Inc. growing?
CLMT's revenue grew at roughly -4.1% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Calumet, Inc. have?
As of fiscal year 2025, CLMT carried roughly $2.23B in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Calumet, Inc.'s gross margin?
CLMT's gross margin was 5.9% in fiscal 2025 — gross profit of $245.70M on revenue of $4.14B.
What is Calumet, Inc.'s market cap?
Calumet, Inc. (CLMT) has a market capitalization of about $3.07B, based on the latest data in our nightly-refreshed cache.
When does Calumet, Inc.'s fiscal year end?
CLMT's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into CLMT stock?
At today's market cap of $3.07B, Calumet, Inc. is priced for free-cash-flow growth of about 21.3% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $56.60M from the FY ending 2025-12-31).
Where does this data come from?
All figures are computed from Calumet, Inc.'s official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.